Stem (NYSE:STEM) Stock Rating Lowered by Guggenheim

Stem (NYSE:STEMGet Free Report) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating in a report issued on Friday, MarketBeat.com reports.

STEM has been the topic of a number of other reports. Evercore ISI increased their price objective on Stem from $11.00 to $17.00 and gave the company an “outperform” rating in a research report on Friday, September 8th. Piper Sandler decreased their price objective on Stem from $5.00 to $4.00 and set a “neutral” rating on the stock in a research report on Friday, October 6th. Roth Mkm decreased their price objective on Stem from $6.00 to $3.70 and set a “neutral” rating on the stock in a research report on Wednesday. BNP Paribas initiated coverage on Stem in a research note on Friday, October 20th. They set a “neutral” rating and a $5.00 price objective for the company. Finally, Bank of America lifted their price objective on Stem from $5.00 to $6.00 and gave the stock an “underperform” rating in a research note on Thursday, July 20th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $9.33.

Get Our Latest Research Report on Stem

Stem Stock Performance

NYSE:STEM opened at $3.67 on Friday. The stock has a market capitalization of $571.79 million, a P/E ratio of -2.89 and a beta of 2.18. The company has a current ratio of 1.99, a quick ratio of 1.52 and a debt-to-equity ratio of 1.01. Stem has a 1 year low of $3.00 and a 1 year high of $14.83. The firm has a 50 day moving average of $4.18 and a 200-day moving average of $5.06.

Stem (NYSE:STEMGet Free Report) last released its quarterly earnings results on Thursday, August 3rd. The company reported ($0.56) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.33). The business had revenue of $92.95 million for the quarter, compared to the consensus estimate of $94.19 million. Stem had a negative return on equity of 26.21% and a negative net margin of 22.92%. As a group, sell-side analysts anticipate that Stem will post -0.88 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CRO Alan Russo sold 13,427 shares of the business’s stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $6.50, for a total value of $87,275.50. Following the sale, the executive now directly owns 139,594 shares in the company, valued at $907,361. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director David S. Buzby purchased 62,000 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were bought at an average cost of $4.82 per share, for a total transaction of $298,840.00. Following the completion of the acquisition, the director now directly owns 620,711 shares in the company, valued at approximately $2,991,827.02. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CRO Alan Russo sold 13,427 shares of the business’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $6.50, for a total value of $87,275.50. Following the completion of the sale, the executive now owns 139,594 shares in the company, valued at $907,361. The disclosure for this sale can be found here. Corporate insiders own 9.12% of the company’s stock.

Institutional Trading of Stem

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Principal Financial Group Inc. raised its holdings in Stem by 39.3% during the third quarter. Principal Financial Group Inc. now owns 21,067 shares of the company’s stock worth $89,000 after acquiring an additional 5,941 shares in the last quarter. Olympiad Research LP bought a new stake in Stem during the third quarter worth about $305,000. SCP Investment LP raised its holdings in Stem by 303.9% during the third quarter. SCP Investment LP now owns 164,800 shares of the company’s stock worth $699,000 after acquiring an additional 124,000 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Stem by 16.3% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 35,187 shares of the company’s stock worth $149,000 after acquiring an additional 4,924 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Stem by 7.3% during the third quarter. Bank of New York Mellon Corp now owns 646,918 shares of the company’s stock worth $2,743,000 after acquiring an additional 43,859 shares in the last quarter. Institutional investors own 64.45% of the company’s stock.

Stem Company Profile

(Get Free Report)

Stem, Inc operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. The company offers energy storage systems sourced from original equipment manufacturers (OEMs). It also provides Athena, an artificial intelligence platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

Read More

Analyst Recommendations for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.